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T
 
HE
 
 traditional view of growth factor receptors and
hormone receptors in general is that a specific
ligand directly recognizes a highly selective binding
site on its cognate receptor and, thereby, activates recep-
tor-dependent signaling and biological responses. In the
case of the EGF receptor, several structurally related pro-
teins (EGF, transforming growth factor alpha, amphiregu-
lin, betacellulin, epiregulin, heparin-binding EGF) are rec-
ognized as direct agonists. Each of these growth factors
binds to the ectodomain of the EGF receptor and pro-
vokes its activation through a mechanism that involves
dimerization, activation of the receptor tyrosine kinase cy-
tosolic domain, and autophosphorylation of the receptor.
This process initiates signaling pathways that lead to mito-
genesis.
Recently it has become apparent that the EGF receptor
is also part of signaling networks activated by stimuli that
do not directly interact with this receptor. These stimuli in-
 
clude agonists that specifically bind to other membrane
receptors, membrane depolarization agents, and envi-
ronmental stressors. The data not only show EGF-inde-
pendent tyrosine phosphorylation of the EGF receptor,
but also provide experimental evidence that the EGF re-
ceptor participates in the signaling events and cellular re-
sponses initiated by these various stimuli. Collectively, the
results imply that in the absence of direct agonists the
EGF receptor is employed in a wide array of biological
signaling processes. The purpose of this article is to review
and evaluate these nonclassical uses of the EGF receptor.
 
G Protein–coupled Receptor Agonists
 
Agonists for a diverse group of G protein–coupled recep-
 
tor (GPCR)
 
1 
 
agonists (purogenic, muscarnic acetylcho-
line, angiotensin, lysophosphatidic acid [LPA], thrombin,
endothelin, adrenergic, and bombesin) have been demon-
strated to bring about increased levels of phosphotyrosine
on the EGF receptor (reviewed in Hackel et al., 1999; Lut-
trell et al., 1999a). Since GPCRs can induce cell prolifera-
tion in certain circumstances (reviewed in Gutkind et al.,
1998), these observations suggest that GPCR-dependent
mitogenic activity involves receptor networking that cou-
ples GPCRs to a growth factor receptor tyrosine kinase.
The important issue is whether the EGF receptor is a nec-
essary component for GPCR mitogenic signaling. Numer-
 
ous reports have now demonstrated that either over-
expression of a dominant-negative EGF receptor or the
 
presence of a specific pharmacologic inhibitor of EGF
receptor tyrosine kinase activity significantly uncouples
GPCR-driven mitogenic responses (Daub et al., 1996,
1997; Tsai et al., 1997; Zwick et al., 1997; Cunnick et al.,
1998; Eguchi et al., 1998; Gohla et al., 1998, 1999; Iwasaki
et al., 1998; Keely et al., 1998; Li et al., 1998; Murasawa et
al., 1998; Soltoff, 1998; Vainganker and Martins-Green,
1998; Adomeit et al., 1999; Della Rocca et al., 1999; Eguchi
et al., 1999; Moriguchi et al., 1999). In these reports, a vari-
ety of biological endpoints (activation of MAP kinase, ty-
rosine phosphorylation of known substrates, gene expres-
sion, stress fiber formation, DNA synthesis) have been
measured in both transfected and untransfected cell lines
as well as primary cells. In a different approach, Cunnick
et al. (1998) demonstrated that B82L cells (an EGF recep-
tor negative cell line) did not produce a mitogenic re-
sponse to LPA unless exogenous EGF receptors were
expressed. When kinase-negative EGF receptors were ex-
pressed in these cells, LPA did not produce a mitogenic
response. Hence, the capacity of GPCRs to transduce a
mitogenic response requires an EGF receptor and its ty-
rosine kinase activity. The consistency of these reports re-
inforces the overall conclusion and its biological signifi-
cance. Clearly, EGF receptor transactivation may be only
one of several independent pathways emanating from
GPCRs and inputs from other pathways may also be es-
sential for mitogenic signaling. Bradykinin stimulation of
protein kinase C seems to be such a required pathway
functioning in parallel to EGF receptor–dependent signal-
ing (Adomeit et al., 1999).
In nearly all examples cited, heterologous modulation of
the EGF receptor occurs too quickly to invoke a mecha-
nism involving the induced synthesis of EGF-like ligands
and in some cases this possibility has been directly tested
and ruled out. Less well explored, however, is the possibil-
ity that heterologous stimuli might stimulate the pro-
teolytic release of cell surface EGF-like growth factor pre-
cursors to soluble and diffusible receptor agonists. Since
GPCR activation produces a small amount of EGF recep-
tor tyrosine phosphorylation compared with a saturating
dose of EGF, only a low level of growth factor would have
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to be produced. However, in view of other data cited be-
low and in the absence of direct data, this mechanism
seems unlikely at present.
The mechanism by which GPCRs actually bring about
tyrosine phosphorylation of the EGF receptor is centered
on the mediation of the non-receptor tyrosine kinase
c-Src, which is reported to be coupled to nearly all GPCRs
that lead to EGF receptor phosphorylation (reviewed in
Thomas and Brugge, 1997). Overexpression of either a
dominant-negative Src construct or Csk, a regulatory ki-
nase that inhibits Src function, decreases EGF receptor ty-
rosine phosphorylation provoked by activation of LPA or
 
a
 
2 adrenergic receptors (Luttrell et al., 1997). The media-
tor role of Src may, in fact, be direct in that Src is able to
associate with and phosphorylate the EGF receptor in
vivo and in vitro (Thomas and Brugge, 1997). This mecha-
nism would predict the existence of Src–EGF receptor
complexes provoked by activation of GPCR. The evidence
for this is shown by the demonstrations that angiotensin II
(Eguchi et al., 1998) or LPA (Luttrell et al., 1997) rapidly
increase the amount of Src coprecipitated with EGF re-
ceptors.
The EGF receptor autophosphorylates at five known ty-
rosine residues after the addition of EGF. Src-induced
EGF receptor phosphorylation has been mapped to most
of these sites as well as novel sites. Of particular interest is
phosphorylation of Tyr 845 in the EGF receptor, which
has been mapped for both in vivo and in vitro Src phos-
phorylation and which is not a known autophosphoryla-
tion site (Sato et al., 1995; Biscardi et al., 1999). This resi-
due is highly conserved in tyrosine kinases and in many
kinases has a regulatory role. In the EGF receptor, Tyr
845 is predicted to be in the activation loop of the tyrosine
kinase domain and, therefore, could function as an activa-
tion trigger to increase activity of the kinase domain.
There are several indications that the kinase catalytic ac-
tivity of the EGF receptor is necessary to mediate GPCR-
dependent mitogenic responses. First, chemical inhibitors
reasonably specific for the EGF receptor tyrosine ki-
nase and competitive with ATP, which suggests an active
site mechanism, block GPCR induction of mitogenic re-
sponses. Second, a point mutant, kinase-negative EGF re-
ceptor does not support GPCR mitogenic signaling (Cun-
nick et al., 1998). Therefore, it seems unlikely that the
receptor is simply phosphorylated by Src and acting as an
inert docking site for SH2-containing signal transducers.
An outstanding issue is whether GPCRs and/or Src induce
dimerization of EGF receptors, a hallmark of EGF-depen-
dent receptor activation. There is but one report (Tsai et
al., 1997) which describes carbachol-induced EGF recep-
tor dimerization.
Mutagenesis of Tyr 845 in the EGF receptor does not at-
tenuate EGF-dependent receptor autophosphorylation or
signaling, but does prevent DNA synthesis induction by
the GPCR agonist LPA (Gotoh et al., 1992; Tice et al.,
1999). However, reports of this mutant include an incon-
sistency. In the latter report this mutant also attenuated
EGF-induced DNA synthesis, while in the former report it
did not. Recently, cells genetically deficient for multiple
Src family kinase have been described (Klinghoffer et al.,
1999). It will be informative to test the Src requirement for
GPCR coupling to the EGF receptor in those cells. That
 
Src may act upstream of the EGF receptor is complicated
by the fact that EGF often produces Src activation. Hence,
depending on the agonist Src may be upstream and/or
downstream of the EGF receptor.
The means by which GPCRs activate Src is not under-
stood. However, there is sufficient data to support two al-
ternative potential mechanisms. Many GPCRs that lead to
EGF receptor phosphorylation are coupled to G proteins
that activate phospholipase C activity provoking Ca
 
2
 
1
 
 mo-
bilization. Ca
 
2
 
1
 
 mobilization can lead to the activation of
the cytoplasmic tyrosine kinase Pyk2. There is evidence
that in certain cell types after GPCR activation, Pyk2 can
associate with Src and that this association may lead to Src
activation, through a mechanism that is unclear (Dikic et
al., 1996; Eguchi et al., 1999; Sayeski et al., 1999). This pu-
tative pathway proceeds as follows: agonist 
 
® 
 
GPCR 
 
®
 
heterotrimeric G protein 
 
® 
 
PLC 
 
® 
 
IP
 
3 
 
® 
 
Ca
 
2
 
1 
 
® 
 
Pyk2 
 
®
 
Src 
 
® 
 
EGF receptor. However, this pathway cannot ex-
plain all GPCR activation of Src, as not all agonists that
activate PLC activity bring about Src activation. While
dominant-negative forms of Pyk2 have been shown to
block GPCR activation of MAP kinases, these assays have
not included tyrosine phosphorylation of the EGF recep-
tor. Also, the expression of Pyk2 is not ubiquitous and the
above scenario may not be applicable in all cells.
Recently a second mechanism has received experimen-
tal support (Luttrell et al., 1999b). In this scheme, devel-
oped with 
 
b
 
2
 
 adrenergic receptors, receptor desensitiza-
tion is coupled to Src activation. After its activation cycle,
the 
 
b
 
-adrenergic receptor is phosphorylated by specific
serine/threonine protein kinases termed 
 
b
 
ark kinases.
These receptor phosphorylation sites then bring about as-
sociation of the adaptin-type molecule 
 
b
 
-arrestin, which
recruits the receptor into coated pits. Evidence is pre-
sented that Src is recruited to the adrenergic receptor–
 
b
 
-arrestin complex by interacting with 
 
b
 
-arrestin and is ac-
tivated by this interaction. Such a pathway would proceed
as follows: agonist 
 
®
 
 GPCR 
 
®
 
 heterotrimeric G protein
 
®
 
 
 
b
 
ark phosphorylation of GPCR 
 
®
 
 arrestin: GPCR
complex 
 
® 
 
GPCR-arrestin-Src complex 
 
®
 
 EGF receptor.
 
Cytokine Receptors
 
This large family of receptors is coupled to JAK family
non-receptor tyrosine kinases. Recently it has been re-
ported that activation of the growth hormone or prolactin
receptors leads to Jak2-dependent tyrosine phosphoryla-
tion of the EGF receptor (Yamaguchi et al., 1997). In cells
expressing the EGF receptor, growth hormone was able to
promote GRB-2 association with the EGF receptor, MAP
kinase activation, and c-
 
fos
 
 induction. These growth hor-
mone–dependent events were also produced with a ki-
nase-negative EGF receptor indicating that only the adap-
tor-docking function of the EGF receptor was essential
and not receptor kinase activity. This is in contrast to the
previously described EGF receptor kinase activity re-
quirement for GPCR-induced mitogenesis. The mecha-
nism by which growth hormone stimulates tyrosine phos-
phorylation of EGF receptor was shown to include JAK-2
activation and the formation of growth hormone receptor–
EGF receptor heterodimers. Src participation was ruled
out. In vitro experiments indicated that JAK-2 may di- 
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rectly phosphorylate the EGF receptor at sites that in-
clude Tyr 1086, a known GRB-2–association site.
 
Adhesion Receptors
 
While there is considerable experimental evidence that ac-
tivation of integrin receptors and cell adhesion in general
can modulate EGF responses and postreceptor signaling
events, the possibility that integrins influence EGF recep-
tor function, per se, is suggested by two reports. In one
study beads coated with ligands that induce integrin aggre-
gation and activation were added to cells and observed to
induce the clustering of EGF receptors around the beads
(Miyamoto et al., 1996). This suggested the coaggregation
of integrin and EGF receptors. Other growth factor recep-
tors (platelet-derived growth factor, fibroblast growth fac-
tor) were also coclustered with the beads. While the EGF
receptors that clustered around these beads were not ty-
rosine phosphorylated, the growth factor–dependent acti-
vation of the EGF receptor was enhanced by the beads.
This could be explained either by exclusion of phos-
phatases from the clusters or by the fact that preclustering
increased cross-phosphorylation of EGF receptors after
ligand addition. Beads with ligands that induced only inte-
grin receptor aggregation and not activation did not pro-
duce EGF receptor clustering around the beads.
Subsequently, a second report (Jones et al., 1997) pre-
sented similar observations from a system in which tenas-
cin C, a collagen-binding glycoprotein that also binds to
and activates integrin receptors, was added to smooth
muscle cells. However, in this cell system cross-linking of
integrin receptors, without activation, was sufficient to in-
duce EGF receptor clustering.
In a more recent study using fibroblasts and endothelial
cells, cell plating on a fibronectin matrix was shown to pro-
duce rapid and transient tyrosine phosphorylation of the
EGF receptor (Moro et al., 1998). Similar results were ob-
tained when the cells were plated on a matrix coated with
integrin receptor antibodies that cluster but do not acti-
vate integrin receptors. Cell adhesion mediated by poly-
 
L
 
-lysine did not activate EGF receptors in this system.
Mechanistically, it was shown that the 
 
b
 
1 integrin receptor
subunit coprecipitated EGF receptors in a manner that de-
pended on cell adhesion, i.e., coprecipitation did not occur
in cells kept in suspension before lysis. Also, the capacity
of fibronectin to increase EGF receptor tyrosine phosphor-
ylation was abrogated by the EGF receptor selective in-
hibitor AG1478 and did not occur in cells expressing a ki-
nase-negative receptor mutant. These results imply that
receptor phosphorylation is a consequence of fibronectin-
enhanced activity of the receptor tyrosine kinase. Also,
this study used both the AG1478 inhibitor and a domi-
nant-negative EGF construct to show that fibronectin acti-
vation of MAP kinase requires EGF receptor function.
Similar reagents also were used to demonstrate that EGF
receptor function was necessary to protect cells from apop-
tosis when plated on fibronectin in the absence of growth
factors. Further evidence with selective chemical inhibi-
tors indicate the role of the EGF receptor in mediating
this resistance to apoptosis was, in fact, not due to MAP
kinase activation but rather seem dependent on phospha-
tidylinositol 3-kinase activity.
It should be pointed out that integrin-dependent ty-
rosine phosphorylation of PDGF receptors has been re-
ported (Sunberg and Rubin, 1996; Schneller et al., 1997)
and the means by which integrins communicate with re-
ceptors tyrosine kinases may lead to the activation of mul-
tiple growth factor receptors, depending on the cells em-
ployed.
Finally, the collagen-binding proteoglycan decorin has
been reported to produce in A-431 cells tyrosine phosphor-
ylation of the EGF receptor and to mobilize Ca
 
2
 
1
 
 and acti-
vate MAP kinase in a manner dependent on the tyrosine
kinase activity of the EGF receptor (Moscatello et al.,
1998; Patel et al., 1998). Decorin is not known to interact
with integrin or other cell adhesion receptors, but a recent
report suggest that it may, in fact, interact directly with the
EGF receptor as a low-affinity agonist (Iozzo et al., 1999).
 
Membrane Depolarization
 
In many cells and, in particular, cells of the nervous sys-
tem, electrical activity initiates intracellular signaling path-
ways and the generation of cellular responses, such as se-
cretion. In PC-12 cells the application of KCl leads to
altered electrical potential across the plasma membrane
and activation of the Ras/MAP kinase pathway. The initi-
ating event seems to be an influx of extracellular Ca
 
2
 
1
 
 elic-
ited by the activation of voltage-sensitive Ca
 
2
 
1
 
 channels.
The artificial influx of Ca
 
2
 
1
 
 by ionophore treatment can
mimic these responses. In these cells, increased levels of
intracellular Ca
 
2
 
1
 
 result in enhanced levels of EGF, but
not insulin or nerve growth factor, receptor tyrosine phos-
phorylation (Rosen and Greenberg, 1996). Transient ex-
pression of dominant-negative EGF receptors or appli-
cation of the selective EGF kinase inhibitor AG1478
prevents the capacity of KCl or ionomycin to increase
EGF receptor tyrosine phosphorylation and activate MAP
kinases in PC12 cells (Zwick et al., 1997). Since the EGF
receptor is widely expressed in cells of the nervous system,
these results may suggest it has role in either the nonmito-
genic signaling events present in these specialized cells or
in preventing programmed cell death.
The means by which intracellular Ca
 
2
 
1
 
 levels may pro-
voke EGF receptor tyrosine phosphorylation are thought
to revolve about the Pyk2 and Src families of tyrosine ki-
nases, which are both known to be activated by membrane
depolarization (Thomas and Brugge, 1997). This pathway
(Ca
 
2
 
1
 
 
 
®
 
 Pyk 
 
®
 
 Src 
 
®
 
 EGF receptor) is analogous to that
described previously for GCPRs. Interestingly, calmodu-
lin-dependent protein kinase has been implicated in EGF
receptor tyrosine phosphorylation after membrane depo-
larization by KCl, but not by GPCRs (Zwick et al., 1999).
 
Stress Response
 
The application of certain exogenous stimuli, both physi-
cal and chemical, initiates signal transduction pathways in
cells that are part of stress responses. Typically, such stim-
uli activate members of the MAP kinase family and pro-
voke the expressions of genes. The following stress stimuli
have been shown to increase the level of tyrosine phos-
phate on the EGF receptor; arsenite (Chen et al., 1998),
sulfhydryl reagents (Knebel et al., 1996), UV radiation 
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(Zheng et al., 1993; Warmuth et al., 1993 and later refer-
ences below), gamma irradiation (Schmidt-Ullrich et al.,
1996, 1997; Goldkorn et al., 1997), hyperosmotic condi-
tions (King et al., 1989; Rosette and Karin, 1996), oxidants
(Knebel et al., 1996; Rao, 1996; Höker et al., 1998; Peus et
al., 1998), and heat shock (Lin et al., 1997). The tyrosine
phosphorylation of other receptor tyrosine kinases is also
affected and the influence on the EGF receptor can not be
characterized as specific. However, in a number of in-
stances the capacity of these stressors to activate MAP ki-
nases and provoke the expression of certain genes is
blocked by selective chemical inhibitors of EGF receptor
tyrosine kinase activity and/or by the expression of domi-
nant-negative EGF receptors. These results imply that
EGF receptor involvement is a necessary element for the
initiation of signaling in response to such stimuli.
Perhaps the most investigated stress stimulus, as it re-
lates to the EGF receptor, is UV radiation. UVA, UVB,
and UVC have all been shown to very rapidly, within sec-
onds, promote enhanced tyrosine phosphorylation of the
EGF receptor. Also, UV induces the phosphotyrosine-
dependent association of signaling molecules, such as GRB-2,
with the receptor and induces the tyrosine phosphoryla-
tion of EGF receptor substrates, such as Shc and PLC-
 
g
 
1
(Huang et al., 1996; Knebel et al., 1996; Rosetto and Karin,
1996). That functional receptors are produced by UV ex-
posure is also indicated by studies demonstrating the for-
mation of receptor dimers, receptor aggregation, and re-
ceptor internalization (Rosette and Karin, 1996). Hence,
by many parameters, UV seems to provoke receptor acti-
vation that mimics addition of a direct ligand. It is clear,
however, that UV does not provoke receptor activation by
a means that involves autocrine production of EGF-family
agonist. Less clear, though unlikely, is the possibility that
stressors promote the proteolytic release of an EGF family
molecule from cell surface precursors. However, as UV
activates v-erbB, an oncogenic isoform of the chicken
EGF-receptor that lacks a ligand-binding domain, the
possible role of ligand involvement would seem unlikely
(Knebel et al., 1996).
That it is the kinase activity of the EGF receptor that
promotes receptor autophosphorylation is indicated by
the fact that selective kinase inhibitors, such as AG1478
(Knebel et al., 1996) and tyrphostin 23 (Miller et al., 1994)
block UV-induced EGF receptor phosphorylation. Simi-
larly, expression of a dominant-negative EGF receptor
prevents UV-induced receptor phosphorylation presum-
ably by the formation of dimers incapable of cross-phos-
phorylation (Huang et al., 1996). Finally, in cells express-
ing a kinase-negative EGF receptor, UV exposure did not
increase receptor tyrosine phosphorylation (Coffer et al.,
1995). Hence, the evidence suggests that UV stress acti-
vates the kinase domain and that EGF receptor phosphor-
ylation is not primarily a consequence of phosphorylation
by other kinases. There is one reported exception in cells
expressing kinase-negative EGF receptors and wild-type
ErbB-2 (Knebel et al., 1996). UV does activate ErbB-2
and ErbB-2, which heterodimerizes with EGF receptors, is
able to cross-phosphorylate the EGF receptor. While UV
does seem to mimic growth factor activation of the recep-
tor, no phosphotyrosine maps have been published for
UV-activated EGF receptors. Therefore, it is not clear
 
that UV and growth factors result in identical receptor ac-
tivation.
UV treatment of cells activates a plethora of signaling
pathways. Experiments using chemical inhibitors of the
EGF receptor or expression of dominant-negative recep-
tor mutants show that the EGF receptor mediates, at least
in part, several UV-induced signaling events, including ac-
tivation of erk1 and 2, production of prostaglandins and
leukotrienes, and the expression of several genes including
c-
 
fos
 
 and 
 
erg
 
-1 (Miller et al., 1994; Huang et al., 1996; Sach-
senmaier et al., 1996).
Less clear is the mechanism by which UV actually acti-
vates the EGF receptor. The prevailing evidence would
suggest that the activation is indirect through inactivation
of phosphotyrosine phosphatase activity. UV is known to
produce reactive oxygen species in cells, perhaps through
the generation of H
 
2
 
O
 
2
 
. Interestingly, EGF also promotes
H
 
2
 
O
 
2
 
 formation in cells (Bae et al., 1997). Several studies
have shown that preincubation with antioxidants, such as
 
N
 
-acetylcysteine, prevent UV but not EGF-induced recep-
tor autophosphorylation (Huang et al., 1996; Knebel et al.,
1996; Miller et al., 1994; Peus et al., 1998). Reducing agents
also protect against UV-induced receptor activation. As
the catalytic sites of phosphotyrosine phosphatase have a
highly conserved sulfhydryl group as an essential element,
this is the likely target for oxidation-induced by UV. There
is experimental evidence at the biochemical level which
shows that a phosphatase-containing membrane prepara-
tion can dephosphorylate a second membrane preparation
that contains activated EGF receptor (Knebel et al., 1996).
The rate of receptor dephosphorylation in this system is
markedly decreased by UV treatment of the phosphatase
preparation before its addition to EGF receptors. This re-
sult implies that basal EGF receptor kinase activity is
quite significant, which is true of purified receptor prepa-
rations.
It is interesting that various stimuli provoke EGF re-
ceptor tyrosine phosphorylation by two distinct means.
While physical and chemical stressors inactivate down-
stream phosphotyrosine phosphatases, heterologous re-
ceptors and membrane depolarization bring about a simi-
lar result by activating upstream tyrosine kinases. It is
possible, however, that this division into separate mecha-
nisms is not absolute and some level of contribution by
kinases and phosphatases exists with each stimulus, as
recently described for carbachol regulation of the Kv1.2
potassium channel (Tsai et al., 1999).
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